Publications by authors named "K Walczak"

Disturbances in carbohydrate metabolism are suggested to be the early symptoms of pancreatic ductal adenocarcinoma (PDAC). The accumulated data suggests that endocrine function-related biomarkers may represent a breakthrough in the early detection of PDAC. Factors which may predispose one to the development of PDAC are insulin resistance and hyperinsulinemia.

View Article and Find Full Text PDF

3,4-Dichloro-5-hydroxy-2(5)-furanone and its dibromo analog are highly reactive molecules. Both are members of the 2(5)-furanone family, which are important as pharmacophores present in drugs and natural products. Compounds possessing the 2(5)-furanone skeleton isolated from plants and marine organisms exhibit bioactivity against various microorganisms and viruses and can also be used in other medical treatments.

View Article and Find Full Text PDF
Article Synopsis
  • - Hydroxyapatite (HAP) is widely used in medical fields for bone repair and implants, and recent studies are focusing on making orthopedic implants more biocompatible with HAP.
  • - The research combines HAP with a lipid matrix to enhance the characteristics of poly(lactic acid) (PLA) implants, utilizing the Langmuir-Blodgett method for effective deposition on PLA surfaces.
  • - Results show that a 5:1 mixture of dihexadecyl phosphate (DHP) and HAP improves the surface properties of PLA, potentially leading to better integration into bone and fewer bacteria adhering to the implants.
View Article and Find Full Text PDF

Intense exercise leads to neutrophil extracellular traps (NETs) formation, which triggers cell disintegration. NET, as well as other processes of apoptosis, necrosis, and spontaneous secretion, result in increased levels of cell-free DNA (cf-DNA) in the circulation. An increment of cf-DNA is also observed in autoimmune diseases, such as type 1 diabetes mellitus (T1DM).

View Article and Find Full Text PDF

Dendrimers are covalently bonded globular nanostructures that may be used in the treatment of Alzheimer's disease (AD). Nowadays, AD therapies are focused on improving cognitive functioning and not causal treatment. However, this may change with the use of dendrimers, which are being investigated as a drug-delivery system or as a drug per se.

View Article and Find Full Text PDF